WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 23-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 46'1651 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 8'545  8'517  8'487  8'455  8'424  8'051  7'707  7'597 
Births 82  81  81  80  79  80  89  87 
Surviving infants 82  81  80  80  79  80  88  86 
Pop. less than 5 years 404  400  396  392  390  416  428  430 
Pop. less than 15 years 1'214  1'216  1'218  1'221  1'227  1'356  1'306  1'559 
Female 15-49 years 1'979  1'993  2'007  2'020  2'031  1'995  1'975  1'839 

Number of reported cases

(Click for retrospective incidence data for Austria)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  309  117  36  68 
Mumps
ChartChart
 
Pertussis
ChartChart
  579  370  571  309  117  234  186 
Polio*
ChartChart
 
Rubella
ChartChart
  11  23 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Austria)
Vaccine year result method % card seen                                                
BCG         
DTP1          75 
DTP3          98  81  90 
DTP4          60 
IPV1          98 
HepB_BD          65 
HepB3          98  33 
Hib3          98  72 
JapEnc         
MCV1          96  75  60 
MCV2          87  35 
PCV1         
PCV3         
Pol3          98  71  90 
Rota1         
RotaC         
Rubella1          96 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Austria)
BCG
ChartChart
  90 
DTP1
ChartChart
  93  93  93  93  99  96  96 
DTP3
ChartChart
  83  83  83  83  81  90  90 
HepB3
ChartChart
  83  83  83  83  33 
HepB_BD
ChartChart
 
Hib3
ChartChart
  83  83  83  83  72 
MCV1
ChartChart
  76  76  76  76  75  60 
MCV2
ChartChart
  64  64  64  64  35 
PCV3
ChartChart
 
Pol3
ChartChart
  83  83  83  83  71  90  90 
RotaC
ChartChart
  61  61  61  61 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepIPV 3, 5, 12 months; Yes
DTaPIPV 7 years; Yes
HPV 9 years; +6 months; Yes Females and males
HepB_Pediatric 13 years; Yes
Influenza_Adult Yes elderly and adults with chronic illness, prenant women, Health care workers, Haj and other travelers and other risk groups
Influenza_Pediatric Yes and children with chronic diseases
MMR 11 months; +1 months; Yes catch-up for everybody
MenACWY 12 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Rotavirus 7, 11, 15 weeks; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR           Yes  Yes 
What years does the MYP cover? number           1998 - ongoing  1998 - ongoing 
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number 35    121  121  121  121  121 
Nº districts with DTP3 coverage >=80% number              
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes             
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes          Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%           88  88 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes             

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.